Characterization of methamphetamine effects on the striatal-nigral dynorphin system

Bakhit, 1981, Long term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain, Neuropharmacology, 20, 1135, 10.1016/0028-3908(81)90053-8

Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3

Chesselet, 1983, Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat, Life Sci., 33, 37, 10.1016/0024-3205(83)90438-1

Hanson, 1986, Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatment, Peptides, 7, 983, 10.1016/0196-9781(86)90125-7

Hanson, 1980, Elevation of substance P-like immunoreactivity in rat central nervous system by protease inhibitors, J. Neurochem., 35, 1370, 10.1111/j.1471-4159.1980.tb09011.x

Hanson, 1987, Methamphetamine-induced changes in the striatal-nigral dynorphin system: Role of D1 and D2 receptors, European J. Pharmacol., 144, 245, 10.1016/0014-2999(87)90527-9

Herrera-Marschitz, 1983, Functional studies with the opioid peptide dynorphin: Acute effects of injections into the substantia nigra reticulata of naive rats, Life Sci., 33, 555, 10.1016/0024-3205(83)90563-5

Hong, 1978, Substance P contents of substantia nigra after chronic treatment with antischizophrenic drugs, Neuropharmacology, 17, 83, 10.1016/0028-3908(78)90178-8

Hurn, 1970, Production of reagent antibodies, Meth. Enzymol., 70, 104, 10.1016/S0076-6879(80)70044-7

Innes, 1975, Norepinephrine, epinephrine and the sympathomimetic amines, 477

König, 1963

Letter, 1987, Effect of methamphetamine on neurotensin concentrations in rat brain regions, J. Pharmacol. Exp. Ther., 241, 443

Li, 1986, Regulation of the concentration of dynorphin A1–8 in the striatonigral pathway by the dopaminergic system, Brain Res., 398, 390, 10.1016/0006-8993(86)91502-7

Mayer, 1977, Neural mechanisms subserving pain in man, 31

McLean, 1985, Comparison of the substance P- and dynorphin-containing projections to the substantia nigra: a radioimmunocytochemical and biochemical study, Brain Res., 361, 185, 10.1016/0006-8993(85)91288-0

Merchant, 1987, Effects of amphetamine analogs on neurotensin concentrations in rat brain, European J. Pharmacol., 134, 245

Nylander, 1986, Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat, Brain Res., 380, 34, 10.1016/0006-8993(86)91426-5

Nylander, 1987, Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways, Neuropharmacology, 26, 1295, 10.1016/0028-3908(87)90090-6

Quirion, 1985, Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra, Brain Res., 331, 358, 10.1016/0006-8993(85)91563-X

Ricaurte, 1985, Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals, Science (Wash. DC), 229, 986, 10.1126/science.4023719

Ritter, 1984, Increases of substance P-like immunoreactivity within striatal-nigral structures after subacute methamphetamine treatment, J. Pharmacol. Exp. Ther., 218, 568

Schmidt, 1987, In vitro and in vivo neurochemical effects of methylenedioxymethamphtamine on striatal monoaminergic systems in rat brain, Biochem. Pharmacol., 36, 747, 10.1016/0006-2952(87)90729-5

Skowsky, 1972, The use of thyroglobulin to induce antigenicity to small molecules, J. Lab. Clin. Med., 80, 134

Sonsalla, 1984, Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation, European J. Pharmacol., 105, 185, 10.1016/0014-2999(84)90666-6

Sonsalla, 1986, Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system, Neuropharmacology, 25, 1221, 10.1016/0028-3908(86)90139-5

Stone, 1986, The effects of 3,4-methylenedioxymethamhetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain, European J. Pharmacol., 128, 41, 10.1016/0014-2999(86)90555-8

Suess, 1986, Radioimmunoassays for fish tail uropeptides. I Development of assay and measurement of immunoreactive urotensin I in Catostomus Commersoni brain, pituitary and plasma, J. Pharmacol., 15, 335

Vincent, 1982, Immunochemical evidence for a dynorphin immunoreactive striato-nigral pathway, European J. Pharmacol., 85, 251, 10.1016/0014-2999(82)90477-0

Wen, 1987, Treatment of pain in cancer patients by intrathecal administration of dynorphin, Peptides, 8, 191, 10.1016/0196-9781(87)90186-0

Zamir, 1983, Distribution of immunoreactive dynorphin in the central nervous system of the rat, Brain Res., 280, 81, 10.1016/0006-8993(83)91176-9

Zamir, 1984, A dynorphinergic pathway of leu-enkephalin production in rat substantia nigra, Nature (London), 307, 643, 10.1038/307643a0